Skip to content

Novel Inhibitors of PARP1/2: A Promising Treatment Approach for BRCA-Negative Cancers, Vascular Disease, and Neurodegeneration

Novel inhibitor compounds that interact with the PARP active site to form effective inhibitors for treatment of cancer and vascular disease

Published: 1st December 2020
Novel Inhibitors of PARP1/2: A Promising Treatment Approach for BRCA-Negative Cancers, Vascular Disease, and Neurodegeneration
Source: BillionPhotos.com, stock.adobe.com/uk/82359905, stock.adobe.com
Patents
  • Patent pending
IP Status
  • Patent application submitted
Seeking
  • Licensing